tiprankstipranks
Advertisement
Advertisement

HK:6978 Stock Latest News

Immunotech Biopharm Narrows Interim Loss But Net Liabilities Deepen
Company AnnouncementsImmunotech Biopharm Narrows Interim Loss But Net Liabilities Deepen
8d ago
6978
Immunotech Biopharm Sets August Board Meeting to Approve Interim Results
PremiumCompany Announcements
Immunotech Biopharm Sets August Board Meeting to Approve Interim Results
18d ago
6978
Immunotech Biopharm Advances Liver Cancer Cell Therapies and Begins ATL Commercialization
PremiumCompany Announcements
Immunotech Biopharm Advances Liver Cancer Cell Therapies and Begins ATL Commercialization
3M ago
6978
Immunotech Biopharm Shareholders Unanimously Back All AGM Resolutions
PremiumCompany Announcements
Immunotech Biopharm Shareholders Unanimously Back All AGM Resolutions
4M ago
6978
Immunotech’s Conditional Liver Cancer Application for EAL Rejected, Firm Plans New Trial and Resubmission
PremiumCompany Announcements
Immunotech’s Conditional Liver Cancer Application for EAL Rejected, Firm Plans New Trial and Resubmission
4M ago
6978
Immunotech Biopharm Halts Trading Pending Inside-Information Announcement
PremiumCompany AnnouncementsImmunotech Biopharm Halts Trading Pending Inside-Information Announcement
4M ago
6978
Immunotech Biopharm Sets 2026 AGM With Share Mandate and Board Re-Elections on Agenda
Premium
Company Announcements
Immunotech Biopharm Sets 2026 AGM With Share Mandate and Board Re-Elections on Agenda
5M ago
6978
Immunotech Biopharm Brings Forward 2026 AGM and Adjusts Book Closure Dates
Premium
Company Announcements
Immunotech Biopharm Brings Forward 2026 AGM and Adjusts Book Closure Dates
5M ago
6978
Immunotech Biopharm Widens Annual Loss as Cancer Cell Therapies Advance in China
PremiumCompany Announcements
Immunotech Biopharm Widens Annual Loss as Cancer Cell Therapies Advance in China
5M ago
6978
Immunotech Biopharm Tightens Audit Committee Rules to Bolster Governance
PremiumCompany Announcements
Immunotech Biopharm Tightens Audit Committee Rules to Bolster Governance
5M ago
6978
Immunotech Biopharm Updates Remuneration Committee Terms to Strengthen Governance
PremiumCompany Announcements
Immunotech Biopharm Updates Remuneration Committee Terms to Strengthen Governance
5M ago
6978
Immunotech Biopharm Sets March Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Immunotech Biopharm Sets March Board Meeting to Approve 2025 Annual Results
6M ago
6978
Immunotech Biopharm Places RMB50 Million in EUR/USD-Linked Structured Deposit
PremiumCompany AnnouncementsImmunotech Biopharm Places RMB50 Million in EUR/USD-Linked Structured Deposit
6M ago
6978
Immunotech Biopharm Settles 2023 Bonds via RMB300 Million Convertible Issue
Premium
Company Announcements
Immunotech Biopharm Settles 2023 Bonds via RMB300 Million Convertible Issue
7M ago
6978
Immunotech Biopharm to Issue New Convertible Bonds to Settle 2023 Notes
Premium
Company Announcements
Immunotech Biopharm to Issue New Convertible Bonds to Settle 2023 Notes
7M ago
6978
Immunotech Biopharm Subsidiary Signs RMB9.75 Million Cell Therapy Service Deal With Tasly
PremiumCompany Announcements
Immunotech Biopharm Subsidiary Signs RMB9.75 Million Cell Therapy Service Deal With Tasly
7M ago
6978
Immunotech Biopharm Moves to Refinance 2023 Convertible Bonds via New Issue
PremiumCompany Announcements
Immunotech Biopharm Moves to Refinance 2023 Convertible Bonds via New Issue
7M ago
6978
Immunotech Biopharm Ltd Engages in Strategic Financial Investment
PremiumCompany Announcements
Immunotech Biopharm Ltd Engages in Strategic Financial Investment
9M ago
6978
Immunotech Biopharm Ltd’s Rights Issue Oversubscribed, Raising HK$257.29 Million
PremiumCompany Announcements
Immunotech Biopharm Ltd’s Rights Issue Oversubscribed, Raising HK$257.29 Million
10M ago
6978
Immunotech Biopharm Ltd Announces Board Changes
PremiumCompany AnnouncementsImmunotech Biopharm Ltd Announces Board Changes
11M ago
6978
Immunotech Biopharm Ltd Announces Board Composition and Committee Roles
Premium
Company Announcements
Immunotech Biopharm Ltd Announces Board Composition and Committee Roles
11M ago
6978
Immunotech Biopharm Announces Rights Issue to Raise Up to HK$307.84 Million
Premium
Company Announcements
Immunotech Biopharm Announces Rights Issue to Raise Up to HK$307.84 Million
11M ago
6978

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >